Skip to the page

Data / Form D filings / Axiom Therapeutics Inc.

Axiom Therapeutics Inc.: Form D filing

Axiom Therapeutics Inc., a technology company in Claymont, DE, filed a Form D with the SEC in 2026. The latest, on August 25, 2026, reports $12.3 million sold of a $12.3 million offering to 31 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2093 PHILADELPHIA PIKE #1369, Claymont, DE, 19703
Phone
(513) 874-5502
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2147556

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 25, 2026New notice$12,287,219$12,287,21931Aug 11, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ryan John GeiserExecutive Officer, Director, Promoter
Christopher Patrick Hamilton HaggardExecutive Officer, Director, Promoter
Sofia DahouneDirector

Other technology companies in Delaware that filed recently

Every Form D from the week of Aug 24, 2026 · All recent filings in Delaware · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Axiom Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.